Skip to main content
Clinical Trials/IRCT20220516054868N1
IRCT20220516054868N1
Completed
Phase 1

Evaluation of the effectiveness of botulinum toxin type A injection in reducing salivation and improving quality of life in patients with cerebral palsy

Esfahan University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Cerebral palsy.
Sponsor
Esfahan University of Medical Sciences
Enrollment
30
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Affliction cerebral palsy
  • Drooling score more than 4

Exclusion Criteria

  • Contraindications for injection of Botulinum toxin A
  • Botulinum toxin type A injection in three month ago
  • Perform recent maxillofacial surgery that may interfere with saliva production and flow
  • Receive systemic medication to treat sialorrhea in the last three months

Outcomes

Primary Outcomes

Not specified

Similar Trials